Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/03/2005WO2004041068A3 Guided capsule for wireless endoscopy, biopsy, and drug delivery
11/03/2005WO2004014156A8 A chemical carrier based on a beta-limit dextrin
11/03/2005WO2003066000A3 Formulation comprising bioactive agents and method of using same
11/03/2005WO2003034980A8 A novel pharmaceutical compound containing abacavir sulfate and methods of making and using same
11/03/2005US20050245908 Infusion device and driving mechanism for same
11/03/2005US20050245907 Infusion device and driving mechanism for same
11/03/2005US20050245906 Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
11/03/2005US20050245905 Local drug-delivery system
11/03/2005US20050245904 Medication delivery system and monitor
11/03/2005US20050245903 Method and apparatus for controllably aspirating fluids from surgical sites
11/03/2005US20050245852 System and method for providing therapy to an area of a body
11/03/2005US20050245617 Methods and compositions for the treatment of CNS-related conditions
11/03/2005US20050245599 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
11/03/2005US20050245558 Naltrexone long acting formulations and methods of use
11/03/2005US20050245556 Pharmaceutical preparation containing oxycodone and naloxone
11/03/2005US20050245510 Use of meloxicam formulations in veterinary medicine
11/03/2005US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator
11/03/2005US20050245493 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
11/03/2005US20050245483 Matrix for sustained, invariant and independent release of active compounds
11/03/2005US20050245469 Crystal forms of azithromycin
11/03/2005US20050245468 Anthelmintic composition
11/03/2005US20050245462 Treatment of cancer with 2-deoxyglucose
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005US20050245439 Prevention of joint destruction
11/03/2005US20050244525 with excipient, and substantially free of alpha-unsaturated gamma-lactone; antiinflammatory
11/03/2005US20050244522 Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents
11/03/2005US20050244520 Topical menthol, or a related cooling compound, to induce lubrication
11/03/2005US20050244519 Bulking agent compositions
11/03/2005US20050244514 Flavone and adenosine from Ixeris Sonchifolia Hance is more stable in the lyophilized powder form than in liquid form for injection so that it is easy to control the quality of the product so as to make the medicament safe and effective
11/03/2005US20050244509 Ophthalmic solutions
11/03/2005US20050244506 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide
11/03/2005US20050244505 Immunotherapy compositions, method of making and method of use thereof
11/03/2005US20050244504 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters)
11/03/2005US20050244503 Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
11/03/2005US20050244502 Composition for enhancing absorption of a drug and method
11/03/2005US20050244501 Water-soluble stabilized self-assembled polyelectrolytes
11/03/2005US20050244500 Intravitreal implants in conjuction with photodynamic therapy to improve vision
11/03/2005US20050244499 Method and device for reducing susceptibility to fractures in long bones
11/03/2005US20050244498 cores comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, gelling agents and excipients, having sustained release coatings; higher bioavailability and side effect reduction
11/03/2005US20050244497 Delayed delivery system for acid-sensitive drugs
11/03/2005US20050244496 Controlled-release sedative-hypnotic compositions and methods related thereto
11/03/2005US20050244495 Tranexamic acid formulations
11/03/2005US20050244494 Controlled releases system containing temozolomide
11/03/2005US20050244493 Rapidly disintegrating tablets comprising calcium carbonate
11/03/2005US20050244492 Rapidly disintegrating tablets comprising titanium dioxide
11/03/2005US20050244491 Fast disintegrating meloxicam tablet
11/03/2005US20050244490 Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
11/03/2005US20050244489 Liquid compositions for soft sustained-release capsules and method for production
11/03/2005US20050244488 Methods and formulations for enhansing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
11/03/2005US20050244487 Membrane architectures for ion-channel switch-based electrochemical biosensors
11/03/2005US20050244486 Topical methadone compositions and methods for using the same
11/03/2005US20050244485 Transdermal administration of hydrophilic drugs using a basic permeation enhancer composition
11/03/2005US20050244483 Film preparation and process for preparing the same
11/03/2005US20050244482 Complex face mask and methods of preparation thereof
11/03/2005US20050244479 Sustained release intraocular implants and methods for preventing retinal dysfunction
11/03/2005US20050244478 Anti-excititoxic sustained release intraocular implants and related methods
11/03/2005US20050244477 Tyrosine kinase microsphers
11/03/2005US20050244476 Intraocular implants and methods for improving vision
11/03/2005US20050244475 Biodegradable intravitreal tyrosine kinase implants
11/03/2005US20050244474 Steroid-containing sustained release intraocular implants and related methods
11/03/2005US20050244473 Memantine intravitreal implants
11/03/2005US20050244472 Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
11/03/2005US20050244471 Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
11/03/2005US20050244470 Producing eye insertable drug delivery agent; extruding active ingredient with polyvinyl alcohol free biodegradable polymer; pharmacokinetics
11/03/2005US20050244469 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant
11/03/2005US20050244468 Sustained release intraocular implants and related methods
11/03/2005US20050244467 Extended release biodegradable ocular implants
11/03/2005US20050244465 Drug delivery systems and methods for treatment of an eye
11/03/2005US20050244464 Hypotensive lipid-containing biodegradable intraocular implants and related methods
11/03/2005US20050244463 Sustained release intraocular implants and methods for treating ocular vasculopathies
11/03/2005US20050244461 Controlled release drug delivery systems and methods for treatment of an eye
11/03/2005US20050244459 a blends comprising ethylene-vinyl acetate copolymer and poly(alkyl(meth)acrylates or poly(aromatic(meth)acrylates); implantable medical device; permit stents releasing the bioactive agent over time in vivo; provide clear coats, durability, biocompatibility, and release kinetics; drug delivery device
11/03/2005US20050244458 Sustained release intraocular implants and methods for treating ocular neuropathies
11/03/2005US20050244447 Novel drug dosing regimen
11/03/2005US20050244439 Composition comprising anionic clay layered host material with intercalated functional-active organic compound
11/03/2005US20050244438 Simple and multiple emulsions for decontamination of an organism or surfaces
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244402 Absorption of pain-causing agents
11/03/2005US20050244401 Compositions and methods for reducing lung volume
11/03/2005US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
11/03/2005US20050244383 Method and device for sanitation using bacteriophages
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050244366 Dressing and method of treatment for a wound
11/03/2005US20050244347 Oral care products comprising calcium phosphates
11/03/2005US20050244343 Oral care products comprising silica
11/03/2005US20050244342 Moisturizing foam containing lanolin
11/03/2005US20050244341 Aerodynamically light particles for pulmonary drug delivery
11/03/2005US20050244340 Dry powder compositions
11/03/2005US20050244339 Pharmaceutical aerosol composition
11/03/2005US20050244314 Process and apparatus for producing inhalable medicaments
11/03/2005US20050242103 Insulated color-changing drinking cup
11/03/2005US20050241645 Composition for preventing the transmission of human immunodeficiency syndrome virus
11/03/2005US20050241635 Two-chamber cartridge for propellant-free metering aerosols
11/03/2005US20050241634 Two-chamber cartridge for propellant-free metering aerosols
11/03/2005DE102004019241A1 Injizierbare vernetzte und unvernetzte Alginate und ihre Verwendung in der Medizin und in der ästhetischen Chirurgie Injectable crosslinked and uncrosslinked alginates and their use in medicine and in aesthetic surgery
11/03/2005DE102004017996A1 Stable anionic liposome depot system for prolonged release of protein or peptide drugs, e.g. insulin, comprising phosphatidyl choline, cholesterol, anionic lipid(s) and cationic polymer
11/03/2005DE102004017705A1 Ferromagnetische Kohlenstoff-Nanoröhren, die Biomoleküle tragen, Verfahren zu deren Herstellung und deren Verwendung in Diagnose und Therapie Ferromagnetic carbon nanotubes carrying biomolecules, processes for their preparation and their use in diagnosis and therapy
11/03/2005DE102004014828A1 Pharmaceutical formulation, for oral administration, has a coating of film-forming polymers free of surfactants and anti-foaming agents
11/03/2005DE102004011776A1 Trägersystem in Form von Nanopartikeln auf Proteinbasis zur zellspezifischen Anreicherung von pharmazeutisch aktiven Wirkstoffen Carrier system in the form of nanoparticles protein-based cell-specific enrichment of active pharmaceutical ingredients
11/03/2005DE102004008017A1 Increasing nutrient bioavailability comprises administering a dietary supplement together with a galactomannan or glucomannan
1 ... 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 ... 2991